Cargando…
Tuberculosis control, and the where and why of artificial intelligence
Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478795/ https://www.ncbi.nlm.nih.gov/pubmed/28656130 http://dx.doi.org/10.1183/23120541.00056-2017 |
_version_ | 1783245025794064384 |
---|---|
author | Doshi, Riddhi Falzon, Dennis Thomas, Bruce V. Temesgen, Zelalem Sadasivan, Lal Migliori, Giovanni Battista Raviglione, Mario |
author_facet | Doshi, Riddhi Falzon, Dennis Thomas, Bruce V. Temesgen, Zelalem Sadasivan, Lal Migliori, Giovanni Battista Raviglione, Mario |
author_sort | Doshi, Riddhi |
collection | PubMed |
description | Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training and communication. Alongside the large-scale roll-out required for such interventions to make a significant impact, products must stay abreast of advancing technology over time. The integration of artificial intelligence into new software promises to make processes more effective and efficient, endowing them with a potential hitherto unimaginable. Users can benefit from artificial intelligence-enabled pattern recognition software for tasks ranging from reading radiographs to adverse event monitoring, sifting through vast datasets to personalise a patient's care plan or to customise training materials. Many experts forecast the imminent transformation of the delivery of healthcare services. We discuss how artificial intelligence and machine learning could revolutionise the management of TB. |
format | Online Article Text |
id | pubmed-5478795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-54787952017-06-27 Tuberculosis control, and the where and why of artificial intelligence Doshi, Riddhi Falzon, Dennis Thomas, Bruce V. Temesgen, Zelalem Sadasivan, Lal Migliori, Giovanni Battista Raviglione, Mario ERJ Open Res Review Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training and communication. Alongside the large-scale roll-out required for such interventions to make a significant impact, products must stay abreast of advancing technology over time. The integration of artificial intelligence into new software promises to make processes more effective and efficient, endowing them with a potential hitherto unimaginable. Users can benefit from artificial intelligence-enabled pattern recognition software for tasks ranging from reading radiographs to adverse event monitoring, sifting through vast datasets to personalise a patient's care plan or to customise training materials. Many experts forecast the imminent transformation of the delivery of healthcare services. We discuss how artificial intelligence and machine learning could revolutionise the management of TB. European Respiratory Society 2017-06-21 /pmc/articles/PMC5478795/ /pubmed/28656130 http://dx.doi.org/10.1183/23120541.00056-2017 Text en The content of this work is © the authors or their employers. Design and branding are © ERS 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Review Doshi, Riddhi Falzon, Dennis Thomas, Bruce V. Temesgen, Zelalem Sadasivan, Lal Migliori, Giovanni Battista Raviglione, Mario Tuberculosis control, and the where and why of artificial intelligence |
title | Tuberculosis control, and the where and why of artificial intelligence |
title_full | Tuberculosis control, and the where and why of artificial intelligence |
title_fullStr | Tuberculosis control, and the where and why of artificial intelligence |
title_full_unstemmed | Tuberculosis control, and the where and why of artificial intelligence |
title_short | Tuberculosis control, and the where and why of artificial intelligence |
title_sort | tuberculosis control, and the where and why of artificial intelligence |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478795/ https://www.ncbi.nlm.nih.gov/pubmed/28656130 http://dx.doi.org/10.1183/23120541.00056-2017 |
work_keys_str_mv | AT doshiriddhi tuberculosiscontrolandthewhereandwhyofartificialintelligence AT falzondennis tuberculosiscontrolandthewhereandwhyofartificialintelligence AT thomasbrucev tuberculosiscontrolandthewhereandwhyofartificialintelligence AT temesgenzelalem tuberculosiscontrolandthewhereandwhyofartificialintelligence AT sadasivanlal tuberculosiscontrolandthewhereandwhyofartificialintelligence AT migliorigiovannibattista tuberculosiscontrolandthewhereandwhyofartificialintelligence AT raviglionemario tuberculosiscontrolandthewhereandwhyofartificialintelligence |